TRANSGENIC MICE FOR STUDY OF THE CDK8/19 CYCLIN-DEPENDENT KINASE KINASE-INDEPENDENT MECHANISMS OF ACTION

被引:1
作者
Stavskaya, N., I [1 ]
Ilchuk, L. A. [2 ,3 ]
Okulova, Yu D. [2 ]
Kubekina, M., V [2 ]
Varlamova, E. A. [2 ]
Silaeva, Yu Yu [1 ]
Bruter, A., V [2 ]
机构
[1] Russian Acad Sci, Inst Gene Biol, Moscow, Russia
[2] Russian Acad Sci, Inst Gene Biol, Ctr Precis Genome Editing & Genet Technol Biomed, Moscow, Russia
[3] Prospekt Mira 124, Moscow 129164, Russia
来源
BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY | 2022年 / 06期
关键词
transgenesis; transcription regulation; Cdk8; mediator kinase; kinase-independent functions; TRANSCRIPTION;
D O I
10.24075/vrgmu.2022.066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The CDK8 cyclin-dependent transcription-associated kinase and its less studied paralog, CDK19, regulate the expression of the dependant genes via several mechanisms. CDK8/19 can directly phosphorylate some transcription factors (ICN, STAT1), but at the same time these kinases being a component of the mediator complex regulate transcrition via interaction with chromatin in the promoter and enhancer regions of appropriate genes. Recently the papers have appeared showing that CDK8/19 has kinase-independent mechanisms of action through comparison of the effects of the kinase activity genetic inactivation and chemical inhibition. The study was aimed to generate transgenic mice capable of the induced and tissue-specific expression of the kinase-negative (showing no phosphorylation activity) form of CDK8, CDK8 (D173A), which could be later used to study the CDK8 kinase-independent mechanisms of action in vivo. We obtained four F0 transgenic animals by microinjection of linear DNA into the pronucleus, two of these animals became the ancestors of two distinct lines. The copy number of the integrated construct was measured for all F0 and the lines generated. This model may be used to study the kinase-independent properties of the CDK8/19 proteins.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 46 条
[31]   Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity [J].
Xu, Junyu ;
Li, Hongmei ;
Wang, Xinren ;
Huang, Jianhang ;
Li, Shuwen ;
Liu, Chenhe ;
Dong, Ruinan ;
Zhu, Gaoyuan ;
Duan, Chunqi ;
Jiang, Fei ;
Zhang, Yanmin ;
Zhu, Yuqin ;
Zhang, Tianyi ;
Chen, Yadong ;
Tang, Weifang ;
Lu, Tao .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
[32]   Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition [J].
Guo, Xianan ;
Chen, Huihui ;
Zhou, Yunxiang ;
Shen, Lu ;
Wu, Shijie ;
Chen, Yiding .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (09) :933-944
[33]   Physical Interaction between Cyclin-Dependent Kinase 5 (CDK5) and Clock Factors Affects the Circadian Rhythmicity in Peripheral Oscillators [J].
Ripperger, Juergen A. ;
Chavan, Rohit ;
Albrecht, Urs ;
Brenna, Andrea .
CLOCKS & SLEEP, 2022, 4 (01) :185-201
[34]   Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells [J].
Pepino, Rebeka de Oliveira ;
Coelho, Fernanda ;
Janku, Tatiane Aparecida Buzanello ;
Alencar, Diandra Pinheiro ;
de Azevedo, Walter Figueira, Jr. ;
Canduri, Fernanda .
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (33) :6846-6865
[35]   Cyclin-dependent kinase 7 (CDK7) expression in human hepatocellular carcinoma: association with HCC progression, prognosis and cell proliferative capacity [J].
Liu, Zheran ;
Liu, Dajiao ;
Zhong, Rongrong ;
Su, Qiuyun ;
Zhao, Tiancheng ;
Fu, Fen ;
Liu, Jinsheng ;
Xu, Derong ;
Zeng, Changqing .
TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) :472-+
[36]   Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin [J].
Murthy, Tushar ;
Bluemn, Theresa ;
Gupta, Abhishek K. ;
Reimer, Michael ;
Rao, Sridhar ;
Pillai, Manoj M. ;
Minella, Alex C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (26) :10220-10234
[37]   A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics [J].
Zhang, Li ;
Cheng, Chen ;
Li, Jing ;
Wang, Lili ;
Chumanevich, Alexander A. ;
Porter, Donald C. ;
Mindich, Aleksei ;
Gorbunova, Svetlana ;
Roninson, Igor B. ;
Chen, Mengqian ;
McInnes, Campbell .
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) :3420-3433
[38]   miR-448 inhibits proliferation and induces apoptosis in prostate cancer cells by modulating cyclin-dependent kinase 19 expression [J].
Chen, Ren-Zong ;
Xu, Zhi-Hui ;
Zhang, Jian-Qiu ;
Mao, Zu-Jie ;
Huang, Bang-Gao ;
Zhang, Qi .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06) :6958-6968
[39]   Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth [J].
Zhou, Yubing ;
Han, Chao ;
Li, Duolu ;
Yu, Zujiang ;
Li, Fengmei ;
Li, Feng ;
An, Qi ;
Bai, Huili ;
Zhang, Xiaojian ;
Duan, Zhenfeng ;
Kan, Quancheng .
SCIENTIFIC REPORTS, 2015, 5
[40]   Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma [J].
Barton, Wade C. ;
Kumari, Asha ;
Mack, Zachary T. ;
Schools, Gary P. ;
Quintero, Liz Macias ;
Choi, Alex Seok ;
Rangavajhula, Karthik ;
Arend, Rebecca C. ;
Broude, Eugenia V. ;
Mythreye, Karthikeyan .
CANCERS, 2025, 17 (06)